RocaJunyent advises Grupo Desconecta on majority sale
RocaJunyent has advised Grupo Desconecta on the acquisition of a 70% stake in its share capital by impact fund Creas Impacto II.
The transaction, which sits within the impact investment space, combines equity from Creas—supported by three investors linked to the fund—with financing provided by Impact Bridge through its IB Deuda Impacto España fund.
Grupo Desconecta operates in the mental and emotional health segment for adolescents and their families, an area of activity for investors.
The team
RocaJunyent provided cross-practice advice on the deal, covering corporate M&A, labour and real estate matters. The mandate was led by Cloe Barnils, head of the firm’s life sciences and healthcare practice, alongside M&A team members Guillem Navarro and Ramon Reñé, with support from the labour team including Alberto Novoa and Rubén González.
